{"title":"Mycobacterial Small Heat Shock Proteins: Dissecting Their Roles in Pathogenesis and Development of Therapeutics.","authors":"Subhashree Barik, Pulak Pritam, Ayon Chakraborty, Sreelipta Das, Sakshi Priyadarsini Dutta, Saswati Soumya Mohapatra, Bhavika Gupta, Alok Kumar Panda, Ashis Biswas","doi":"10.1021/acsinfecdis.4c01053","DOIUrl":null,"url":null,"abstract":"<p><p>Small heat shock proteins are a ubiquitous family of molecular chaperones. This class of proteins has a conserved α-crystallin domain. <i>Mycobacterium tuberculosis</i>, the etiological agent that causes tuberculosis (TB), harbors two α-crystallin-related (Acr) small heat shock proteins, Acr1 (Hsp16.3) and Acr2 (HrpA). Both of these proteins have been reported as crucial for the survival and pathogenesis of <i>M. tuberculosis</i> inside the host. Acr1 often plays a critical role in the pathogen's survival in the latent stage, while Acr2 overexpresses following phagocytosis during the active infection and is also required for pathogenesis. The strong immunogenicity of Acr1 and Acr2 has been utilized for developing and boosting vaccines and as a diagnostic marker for active and latent TB. Some recent studies have also implicated the development of drugs against these small heat shock proteins. In addition, several structure-function studies established the role of different stresses on the structure and function of these proteins. However, such studies on Acr2 are few in the literature. In this review, the various biophysical and early diagnostic studies of Acr1 and Acr2 are presented systematically. Subsequently, the role of these Acrs in pathogenesis and toward the development of vaccines against TB is discussed.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.4c01053","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Small heat shock proteins are a ubiquitous family of molecular chaperones. This class of proteins has a conserved α-crystallin domain. Mycobacterium tuberculosis, the etiological agent that causes tuberculosis (TB), harbors two α-crystallin-related (Acr) small heat shock proteins, Acr1 (Hsp16.3) and Acr2 (HrpA). Both of these proteins have been reported as crucial for the survival and pathogenesis of M. tuberculosis inside the host. Acr1 often plays a critical role in the pathogen's survival in the latent stage, while Acr2 overexpresses following phagocytosis during the active infection and is also required for pathogenesis. The strong immunogenicity of Acr1 and Acr2 has been utilized for developing and boosting vaccines and as a diagnostic marker for active and latent TB. Some recent studies have also implicated the development of drugs against these small heat shock proteins. In addition, several structure-function studies established the role of different stresses on the structure and function of these proteins. However, such studies on Acr2 are few in the literature. In this review, the various biophysical and early diagnostic studies of Acr1 and Acr2 are presented systematically. Subsequently, the role of these Acrs in pathogenesis and toward the development of vaccines against TB is discussed.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.